Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer.
LaMarche, M.J., Acker, M., Argintaru, A., Bauer, D., Boisclair, J., Chan, H., Chen, C.H., Chen, Y.N., Chen, Z., Deng, Z., Dore, M., Dunstan, D., Fan, J., Fekkes, P., Firestone, B., Fodor, M., Garcia-Fortanet, J., Fortin, P.D., Fridrich, C., Giraldes, J., Glick, M., Grunenfelder, D., Hao, H.X., Hentemann, M., Ho, S., Jouk, A., Kang, Z.B., Karki, R., Kato, M., Keen, N., Koenig, R., LaBonte, L.R., Larrow, J., Liu, G., Liu, S., Majumdar, D., Mathieu, S., Meyer, M.J., Mohseni, M., Ntaganda, R., Palermo, M., Perez, L., Pu, M., Ramsey, T., Reilly, J., Sarver, P., Sellers, W.R., Sendzik, M., Shultz, M.D., Slisz, J., Slocum, K., Smith, T., Spence, S., Stams, T., Straub, C., Tamez Jr., V., Toure, B.B., Towler, C., Wang, P., Wang, H., Williams, S.L., Yang, F., Yu, B., Zhang, J.H., Zhu, S.(2020) J Med Chem 63: 13578-13594
- PubMed: 32910655 
- DOI: https://doi.org/10.1021/acs.jmedchem.0c01170
- Primary Citation of Related Structures:  
7JVM, 7JVN - PubMed Abstract: 
SHP2 is a nonreceptor protein tyrosine phosphatase encoded by the PTPN11 gene and is involved in cell growth and differentiation via the MAPK signaling pathway. SHP2 also plays an important role in the programed cell death pathway (PD-1/PD-L1). As an oncoprotein as well as a potential immunomodulator, controlling SHP2 activity is of high therapeutic interest ...